The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positiv ...
The ‘elephant problem’ debate tracks this logic: dead or damaged trees with signs of elephants being involved equals evidence ...
Dr. Olivia Greenspan, ND RN Abstract Structured risk factor modification and longitudinal lifestyle care can improve atrial ...